Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Tratamiento quirúrgico para la enfermedad tubárica en mujeres a las que se les realizará fertilización in vitro

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD002125.pub3Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 20 January 2010see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:
  1. Cochrane Gynaecology and Fertility Group

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Neil Johnson

    Correspondence to: Department of Obstetrics & Gynaecology, University of Auckland, Auckland, New Zealand

    [email protected]

  • Sabine van Voorst

    Faculty of Medicine, University of Maastricht, Maastricht, Netherlands

  • Martin C Sowter

    Fertility Plus, Auckand Hospital, Auckland, New Zealand

  • Annika Strandell

    Obstetrics and Gynecology, University of Gothenburg, Kungälv, Sweden

  • Ben Willem J Mol

    Obstetrics and Gynaecology, Máxima Medical Center, Veldhoven, Netherlands

Contributions of authors

Neil Johnson conceptualised the protocol and the review primarily, and carried out the search, selection of trials and risk of bias assessment as a first reviewer and first author in the first version of the review and as a second reviewer in the current update.

Sabine van Voorst conducted the current update by performing the search and selection of trials, risk of bias assessment as a first reviewer and author. Martin Sowter proofread the primary protocol, was available to resolve discrepancies for differences of opinion between the other authors and added content expertise to the discussion and conclusions during the first and updated version of this review.
Ben Willem Mol and Annika Strandell proofread the updated review and added content expertise to the discussion and conclusion.

Sources of support

Internal sources

  • University of Auckland, School of Medicine, Auckland, New Zealand.

External sources

  • No sources of support supplied

Declarations of interest

Two of the authors (MS and AS) have performed clinical studies assessing the interventions studied in this review (Sowter 1997;Strandell 1999), the latter being one of the included RCTs in this review.

Neil Johnson works as a gynaecologist at Auckland City Hospital (a public hospital) in the National Women's Minimal Access Surgery and Endometriosis Service. NJ is also a private gynaecologist with groups called Endometriosis Auckland and Repromed Auckland. Within the last 3 years NJ has received financial support to attend conferences or to arrange research meetings from the following companies: Organon, Serono, Schering and Device Technologies.

Sabine van Voorst at the time was a medical student of the faculty of Health, Medicine and Life Sciences of the University of Maastricht, the Netherlands. She is now a resident in Obstetrics and Gynaecology at the Reinier de Graaf Gasthuis in Delft, the Netherlands. She has no financial conflict of interest.

Annika Strandell is a gynaecologist at Kungälv Hospital, associate professor at the University of Gothenburg and employed at the regional center for Health Technology Assessment in Göteborg, Sweden. She was the principle investigator and co‐ordinator of the Scandinavian trial on salpingectomy for hydrosalpinges prior to IVF. She has no financial conflict of interest.

Acknowledgements

The authors acknowledge the helpful comments of those who have refereed this review and the authors of included trials who supplied additional information or data in the previous and current review, particularly Annika Strandell, Evangelos Makrakis, Herve Déchaud, Nahed Hammadieh and Vaeceslav Moshin . We wish to thank Jane Clarke, MDSG Managing Editor, and Marian Showell, MDSG Trials Search Coordinator. Stephan Bontekoe assisted with copy editing in RevMan 5.

Version history

Published

Title

Stage

Authors

Version

2020 Oct 22

Surgical treatment for tubal disease in women due to undergo in vitro fertilisation

Review

Pedro Melo, Ektoras X Georgiou, Neil Johnson, Sabine F. Voorst, Annika Strandell, Ben Willem J Mol, Christian Becker, Ingrid E Granne

https://doi.org/10.1002/14651858.CD002125.pub4

2010 Jan 20

Surgical treatment for tubal disease in women due to undergo in vitro fertilisation

Review

Neil Johnson, Sabine van Voorst, Martin C Sowter, Annika Strandell, Ben Willem J Mol

https://doi.org/10.1002/14651858.CD002125.pub3

2004 Jul 19

Surgical treatment for tubal disease in women due to undergo in vitro fertilisation

Review

Neil Johnson, Sabine van Voorst, Martin C Sowter, Annika Strandell, Ben Willem J Mol

https://doi.org/10.1002/14651858.CD002125.pub2

2001 Jul 23

Surgical treatment for tubal disease in women due to undergo in vitro fertilisation

Review

Neil NP Johnson, W Mak, M C Sowter

https://doi.org/10.1002/14651858.CD002125

Differences between protocol and review

The current updated review differs from the original protocol in primary outcomes and risk of bias assessment. Definitions of fertility outcomes are applied stricter as of the 2008 update, reflecting current thoughts on fertility outcome (Dias 2006; Clarke 2008). Current risk of bias assessment reflects the current opinion in assessing quality of studies (Higgins 2008).

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.